BRAF and congenital mesoblastic nephroma: Last but not least, considering the fact that mosaic NRAS and BRAF pathogenic variants are abundant in CMN, the researchers generally agree that they initiate congenital nevus development [14], but they do not trigger malignancy on their own [15].